According to Zhitong Finance App, Cansino Biotech (06185.HK) announced that the new drug marketing application (NDA) for adsorbed acell-free 100 (5 components) albinism vaccine (for people aged 6 and above) (Td5CP for adolescents and adults) developed by the company has recently obtained an acceptance notice from the China Drug Administration.

Zhitongcaijing · 2d ago
According to Zhitong Finance App, Cansino Biotech (06185.HK) announced that the new drug marketing application (NDA) for adsorbed acell-free 100 (5 components) albinism vaccine (for people aged 6 and above) (Td5CP for adolescents and adults) developed by the company has recently obtained an acceptance notice from the China Drug Administration.